Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2019 1
2020 2
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Stable Chelation of the Uranyl Ion by Acyclic Hexadentate Ligands: Potential Applications for 230U Targeted α-Therapy.
Woods JJ, Unnerstall R, Hasson A, Abou DS, Radchenko V, Thorek DLJ, Wilson JJ. Woods JJ, et al. Inorg Chem. 2022 Feb 21;61(7):3337-3350. doi: 10.1021/acs.inorgchem.1c03972. Epub 2022 Feb 9. Inorg Chem. 2022. PMID: 35137587 Free PMC article.
Uranium-230 is an alpha-emitting radionuclide with favorable properties for use in targeted alpha-therapy (TAT), a type of nuclear medicine that harnesses alpha particles to eradicate cancer cells. ...
Uranium-230 is an alpha-emitting radionuclide with favorable properties for use in targeted alpha-therapy (TAT), a type of nuc …
Production of 230Pa by proton irradiation of 232Th at the LANL isotope production facility: Precursor of 230U for targeted alpha therapy.
Friend MT, Mastren T, Parker TG, Vermeulen CE, Brugh M, Birnbaum ER, Nortier FM, Fassbender ME. Friend MT, et al. Appl Radiat Isot. 2020 Feb;156:108973. doi: 10.1016/j.apradiso.2019.108973. Epub 2019 Nov 5. Appl Radiat Isot. 2020. PMID: 31727509
Uranium-230 (t(1/2) = 20.8 d) is an alpha-emitting radionuclide that has potential application in targeted alpha therapy (TAT) of cancer. ...
Uranium-230 (t(1/2) = 20.8 d) is an alpha-emitting radionuclide that has potential application in targeted alpha therapy (TAT) …
Production of medical isotopes from a thorium target irradiated by light charged particles up to 70 MeV.
Duchemin C, Guertin A, Haddad F, Michel N, Métivier V. Duchemin C, et al. Phys Med Biol. 2015 Feb 7;60(3):931-46. doi: 10.1088/0031-9155/60/3/931. Epub 2015 Jan 9. Phys Med Biol. 2015. PMID: 25574934
Direct nuclear reaction allows the production of Protactinium-230 which decays to Uranium-230 the mother nucleus of Thorium-226, a promising isotope for alpha radionuclide therapy. ...
Direct nuclear reaction allows the production of Protactinium-230 which decays to Uranium-230 the mother nucleus of Thorium-22 …